Retrospective Analysis of Sacubitril/Valsartan vs Benazepril for Treating Heart Failure Following Acute Myocardial Infarction
Sacubitril/Valsartan is a safe and effective treatment for heart failure post-AMI, offering significant improvements in cardiac function, inflammatory response, exercise capacity, and a reduction in MACE risk.
Authors
- Donghui Qin
- Zhuo Chen (ORCID: https://orcid.org/0000-0001-9991-6892)
- Na Zhang (ORCID: https://orcid.org/0000-0003-0601-4035)
- Li Zhao (ORCID: https://orcid.org/0000-0003-4399-8133)
- Xue Yang (ORCID: https://orcid.org/0000-0003-1623-4234)
- Yuanyuan Ren (ORCID: https://orcid.org/0000-0002-8742-0379)
Institutions
- Qihe People's Hospital (CN)
- Qiqihar Medical University (CN)
Publication Details
- Journal
- International Journal of General Medicine
- Published
- 2024-12-01
- DOI
- https://doi.org/10.2147/ijgm.s496996
- Primary Topic
- Heart Failure Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00